Form 4: Atara Biotherapeutics EVP, Chief Legal Officer Amar Murugan Reports Sale of 10,044 Shares
SEC Form 4 Filing
Amar Murugan, EVP, Chief Legal Officer of Atara Biotherapeutics, sold 10,044 shares of common stock on March 4, 2024, to cover tax withholding obligations.
Summary
- On March 4, 2024, Amar Murugan, the EVP, Chief Legal Officer of Atara Biotherapeutics, sold 10,044 shares of the company's common stock.
- The shares were sold at a price of $0.72 per share.
- The sale was executed to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Murugan directly owns 727,521 shares of Atara Biotherapeutics.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is related to tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This sale is related to tax obligations and may not reflect a change in sentiment regarding the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of stock sale transaction. |
| 03/06/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.